Literature DB >> 11428857

Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells.

U Pleyer1, D Groth, B Hinz, O Keil, E Bertelmann, P Rieck, R Reszka.   

Abstract

Gene transfer to corneal endothelial cells could be an important advance to modulate functions of these critical cells and is a field of current investigations. The development of gene transfer methods is a prerequisite for gene therapy to realize its full potential. We attempted to investigate and optimize the efficacy and safety of cationic liposome mediated gene transfer into corneal endothelial cells using different lipid formulations. Mono- and polycationic lipids and the neutral helper lipid dioleolphosphotidyl-ethanolamine (DOPE) were used for preparation of cationic liposomes. Six liposomal formulations containing DAC/DOPE 30/70 (DAC 30), DOSGA/DOPE 30/70 (DOSGA 30), DOSGA 100, DMRIE/DOPE 50/50 (DMRIE 50) and SP/DOPE 20/80 (SP 20) were complexed with the pUT 651-plasmid, encoding the E. coli beta-galactosidase gene. Subconfluent primary and passaged bovine corneal endothelial cells (BCEC) were transfected with different amounts of liposomes and DNA or uncomplexed free DNA as control. Quantitative expression of beta-galactosidase was measured using a colorimetric assay. In order to assess the effects on cell viability and growth, a modified acidic phosphatase assay was employed. Differences were detected using these various liposome preparations. Transfection experiments demonstrated the highest gene expression using SP 20> DMRIE 50 ranging at approximately 3 mU per beta-gal per well. Low expression of beta-galactosidase was achieved using DAC 30, DOSGA 30 and DOSGA 100. No beta-galactosidase expression was found in control dishes. There was no difference seen following transfection of primary or subsequent passages of BCEC. As indicated by the acid phosphatase assay, no significant toxicity was detected for the most efficient lipids used. Of the preparations studied, SP 20 appeared as the optimal vehicle for plasmid-mediated transfection of BCEC. The ability to deliver genes to BCEC via liposomes could be valuable, since the use of other vectors for transfection may be limited by undesired effects. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428857     DOI: 10.1006/exer.2001.1005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

Review 2.  Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.

Authors:  Crispin R Dass
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

3.  Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells.

Authors:  Li Song; Shujun Ge; Joel S Pachter
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

4.  RNAi inhibits Coriaria lactone-induced MDR1b overexpression in rat brain microvascular endothelial cells.

Authors:  Linyu Tian; Lei Chen; Tianhua Yang; Qin Zhang; Dong Zhou
Journal:  J Mol Neurosci       Date:  2009-04-09       Impact factor: 3.444

5.  Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

Authors:  Ajay Sharma; Ashish Tandon; Jonathan C K Tovey; Rangan Gupta; J David Robertson; Jennifer A Fortune; Alexander M Klibanov; John W Cowden; Frank G Rieger; Rajiv R Mohan
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

6.  Recent applications of liposomes in ophthalmic drug delivery.

Authors:  Gyan P Mishra; Mahuya Bagui; Viral Tamboli; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2011-03-01

7.  Targeting herpetic keratitis by gene therapy.

Authors:  Hossein Mostafa Elbadawy; Marine Gailledrat; Carole Desseaux; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2012-12-26       Impact factor: 1.909

Review 8.  Novel insights into gene therapy in the cornea.

Authors:  Rajiv R Mohan; Lynn M Martin; Nishant R Sinha
Journal:  Exp Eye Res       Date:  2020-11-16       Impact factor: 3.770

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.